ID   SCMC-N5
AC   CVCL_5924
SY   SCMC-N-5; SCMCN5; Saitama Children's Medical Center-Neuroblastoma 5
DR   cancercelllines; CVCL_5924
DR   Cosmic; 801753
DR   Cosmic; 920252
DR   Cosmic; 947698
DR   Cosmic; 1037348
DR   Cosmic; 1099145
DR   Cosmic; 1153791
DR   Cosmic; 2131583
DR   GEO; GSM314018
DR   GEO; GSM333805
DR   JCRB; NIHS0042
DR   Progenetix; CVCL_5924
DR   Wikidata; Q54952462
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=9041193;
RX   PubMed=18923524;
CC   Population: Japanese.
CC   Omics: SNP array analysis.
CC   Discontinued: JCRB; NIHS0042; true.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 13
//
RX   CelloPub=CLPUB00110;
RA   Hayashi Y., Hanada R., Moriwaki K., Yamamoto K., Imaizumi S.,
RA   Hirata A., Nishida T.;
RT   "Establishment and characterization of cell lines derived from
RT   malignant tumors in children.";
RL   Saitama Shoni Iryo Senta Igaku-shi 8:16-23(1991).
//
RX   DOI=10.2198/sbk.34.289;
RA   Mizusawa H.;
RT   "Operation of the JCRB cell bank and isoenzyme.";
RL   Seibutsu Butsuri Kagaku 34:289-292(1990).
//
RX   PubMed=9041193;
RA   Takita J., Hayashi Y., Kohno T., Yamaguchi N., Hanada R., Yamamoto K.,
RA   Yokota J.;
RT   "Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in
RT   neuroblastoma.";
RL   Cancer Res. 57:907-912(1997).
//
RX   PubMed=18923524; DOI=10.1038/nature07399;
RA   Chen Y.-Y., Takita J., Choi Y.L., Kato M., Ohira M., Sanada M.,
RA   Wang L.-L., Soda M., Kikuchi A., Igarashi T., Nakagawara A.,
RA   Hayashi Y., Mano H., Ogawa S.;
RT   "Oncogenic mutations of ALK kinase in neuroblastoma.";
RL   Nature 455:971-974(2008).
//